Clin2
NCT07545525Possibly a fitNot yet recruiting

HPV test before subtotal hysterectomy

Cervical Cancer ScreeningHuman Papilloma Virus (HPV)

Part of Cancer, Infections, Women’s health & pregnancy clinical trials.

This trial checks for HPV before a subtotal hysterectomy (removal of part of the womb) to find and treat early cervical changes. The goal is to prevent cervical cancer and reduce the chance of needing further surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are older than 18 years.
  • You are scheduled for a subtotal hysterectomy (removal of the womb but keeping the cervix).
  • You agree to have a small procedure (cone biopsy) if the HPV test is positive.
  • You have not had a negative HPV test in the last 3 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07214584Recruiting
Using blood and cervical tests to track cervical cancer treatment response

This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.

Gainesville, Florida
NCT07281430Recruiting
HPV self-test for cervical cancer screening

This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.

Birmingham, Alabama
NCT07782697Not yet recruiting
HPV blood test to predict cervical cancer return after surgery

This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.

Hefei
NCT05229679Recruiting
HPV screening for women ages 23 to 29

This study focuses on HPV-based screening for women ages 23–29. It may help confirm whether HPV testing is a good way to find early signs of cervical cancer risk in this age group.

Lund, Skåne County
NCT07077980Not yet recruiting
HPV vaccine for cervical cancer

This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.

Hefei, Anhui
NCT07431502Not yet recruiting· Phase 3
HPV vaccine to prevent recurrence of pre-cancerous lesions

This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.

Hear when a new Cervical Cancer Screening trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.